Obstructive sleep-disordered breathing and plasma levels of vascular endothelial growth factor in children

Respiratory Medicine

Volumn 100, Issue 5, 2006, Pages 835-840

  Kaditis, Athanasios G ^a   Alexopoulos, Emmanouel I ^a   Karadonta, Ioanna ^a   Kostadima, Eleni ^a   Kiropoulos, Theodoros ^a   Gourgoulianis, Konstantinos ^a   Syrogiannopoulos, George A ^a  

^a UNIVERSITY OF THESSALY   (Greece)

Author keywords

Atherosclerosis; Obstructive sleep apnea; Snoring

Indexed keywords

VASCULOTROPIN;

ADOLESCENT; ARTICLE; CHILD; CIRCADIAN RHYTHM; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OXYGEN SATURATION; PATHOPHYSIOLOGY; PREDICTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; SLEEP APNEA SYNDROME; SLEEP TIME; SNORING; STATISTICAL SIGNIFICANCE;

ADOLESCENT; AROUSAL; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; MALE; SLEEP APNEA, OBSTRUCTIVE; SNORING; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 33645840733     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rmed.2005.09.003     Document Type: Article

References (31)

1. Shahar E., Whitney C.W., Redline S., et al. Sleep-disordered breathing and cardiovascular disease: cross-sectional results of the Sleep Heart Health Study. Am J Respir Crit Care Med 163 (2001) 19-25
2. Nieto F.J., Young T.B., Lind B.K., et al. Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study. Sleep Heart Health Study. JAMA 283 (2000) 1829-1836
3. Yokoe T., Minoguchi K., Matsuo H., et al. Elevated levels of C-reactive protein and interleukin-6 in patients with obstructive sleep apnea syndrome are decreased by nasal continuous positive airway pressure. Circulation 107 (2003) 1129-1134
4. Punjabi N.M., Shahar E., Redline S., Gottlieb D.J., Givelber R., and Resnick H.E. Sleep-disordered breathing, glucose intolerance, and insulin resistance: the Sleep Heart Health Study. Am J Epidemiol 160 (2004) 521-530
5. Kraiczi H., Caidahl K., Samuelsson A., Peker Y., and Hedner J. Impairment of vascular endothelial function and left ventricular filling: association with the severity of apnea-induced hypoxemia during sleep. Chest 119 (2001) 1085-1091
6. Marcus C.L., Greene M.G., and Carroll J.L. Blood pressure in children with obstructive sleep apnea. Am J Respir Crit Care Med 157 (1998) 1098-1103
7. Amin R.S., Carroll J.L., Jeffries J.L., et al. Twenty-four-hour ambulatory blood pressure in children with sleep-disordered breathing. Am J Respir Crit Care Med 169 (2004) 950-956
8. Tauman R., Ivanenko A., O'Brien L.M., and Gozal D. Plasma C-reactive protein levels among children with sleep-disordered breathing. Pediatrics 113 (2004) e564-e569
9. de la Eva R.C., Baur L.A., Donaghue K.C., and Waters K.A. Metabolic correlates with obstructive sleep apnea in obese subjects. J Pediatr 140 (2002) 654-659
10. Amin R.S., Kimball T.R., Bean J.A., et al. Left ventricular hypertrophy and abnormal ventricular geometry in children and adolescents with obstructive sleep apnea. Am J Respir Crit Care Med 165 (2002) 1395-1399
11. Ferrara N. Molecular and biological properties of vascular endothelial growth factor. J Mol Med 77 (1999) 527-543
12. Inoue M., Itoh H., Ueda M., et al. Vascular endothelial growth factor (VEGF) expression in human coronary atherosclerotic lesions: possible pathophysiological significance of VEGF in progression of atherosclerosis. Circulation 98 (1998) 2108-2116
13. Belgore F.M., Blann A.D., Li-Saw-Hee F.L., Beevers D.G., and Lip G.Y. Plasma levels of vascular endothelial growth factor and its soluble receptor (SFlt-1) in essential hypertension. Am J Cardiol 87 (2001) 805-807
14. Suzuki A., Miyagawa-Tomita S., Komatsu K., et al. Active remodeling of the coronary arterial lesions in the late phase of Kawasaki disease: immunohistochemical study. Circulation 101 (2000) 2935-2941
15. Suzuki A., Miyagawa-Tomita S., Komatsu K., et al. Immunohistochemical study of apparently intact coronary artery in a child after Kawasaki disease. Pediatr Int 46 (2004) 590-596
16. Imagawa S., Yamaguchi Y., Higuchi M., et al. Levels of vascular endothelial growth factor are elevated in patients with obstructive sleep apnea-hypopnea syndrome. Blood 98 (2001) 1255-1257
17. Schulz R., Hummel C., Heinemann S., Seeger W., and Grimminger F. Serum levels of vascular endothelial growth factor are elevated in patients with obstructive sleep apnea and severe nighttime hypoxia. Am J Respir Crit Care Med 165 (2002) 67-70
18. Lavie L., Kraiczi H., Hefetz A., et al. Plasma vascular endothelial growth factor in sleep apnea syndrome: effects of nasal continuous positive air pressure treatment. Am J Respir Crit Care Med 165 (2002) 1624-1628
19. Teramoto S., Kume H., Yamamoto H., et al. Effects of oxygen administration on the circulating vascular endothelial growth factor (VEGF) levels in patients with obstructive sleep apnea syndrome. Intern Med 42 (2003) 681-685
20. Gozal D., Lipton A.J., and Jones K.L. Circulating vascular endothelial growth factor levels in patients with obstructive sleep apnea. Sleep 25 (2002) 59-65
21. Jelkmann W. Pitfalls in the measurement of circulating vascular endothelial growth factor. Clin Chem 47 (2001) 617-623
22. Valipour A., Litschauer B., Mittermayer F., Rauscher H., Burghuber O.C., and Wolzt M. Circulating plasma levels of vascular endothelial growth factor in patients with sleep disordered breathing. Respir Med 98 (2004) 1180-1186
23. Kaditis A.G., Alexopoulos E.I., Kalampouka E., et al. Morning levels of fibrinogen in children with sleep-disordered breathing. Eur Respir J 24 (2004) 790-797
24. Kaditis A.G., Alexopoulos E.I., Kalampouka E., et al. Morning levels of C-reactive protein in children with obstructive sleep-disordered breathing. Am J Respir Crit Care Med 171 (2005) 282-286
25. Rechtschaffen A., and Kales A. A manual of standardized terminology: techniques and scoring systems for sleep stages of human subjects (1968), UCLA Brain Information Service/Brain Research Institute, Los Angeles
26. American Sleep Disorders Association. EEG arousals: scoring rules and examples: a preliminary report from the Sleep Disorders Atlas Task Force of the American Sleep Disorders Association. Sleep 15 (1992) 173-184
27. American Thoracic Society. Standards and indications for cardiopulmonary sleep studies in children. Am J Respir Crit Care Med 153 (1996) 866-878
28. Ogden C.L., Kuczmarski R.J., Flegal K.M., et al. Centers for Disease Control and Prevention 2000 growth charts for the United States: improvements to the 1977 National Center for Health Statistics version. Pediatrics 109 (2002) 45-60
29. Malamitsi-Puchner A., Tziotis J., Tsonou A., Protonotariou E., Sarandakou A., and Creatsas G. Changes in serum levels of vascular endothelial growth factor in males and females throughout life. J Soc Gynecol Invest 7 (2000) 309-312
30. Ferrara N., Heinsohn H., Walder C.E., Bunting S., and Thomas G.R. The regulation of blood vessel growth by vascular endothelial growth factor. Ann N Y Acad Sci 752 (1995) 246-256
31. Forsythe J.A., Jiang B.H., Iyer N.V., et al. Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol Cell Biol 16 (1996) 4604-4613